Search Results - "Othman, Tamer A."

Venetoclax-based combinations for the treatment of newly diagnosed acute myeloid leukemia by Othman, Tamer A, Azenkot, Tali, Moskoff, Benjamin N, Tenold, Matthew E, Jonas, Brian A

“…Elderly and/or unfit patients with acute myeloid leukemia have historically been challenging to manage as they were ineligible for what was considered standard…”
Get full text

Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents by Othman, Tamer A., Mei, Matthew, Zhang, Jianying, Aldoss, Ibrahim, Stein, Anthony, Forman, Stephen J., Marcucci, Guido, Pullarkat, Vinod

Get full text

Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy by Othman, Tamer A., Zhang, Jianying, Mei, Matthew, Stein, Anthony S., Forman, Stephen J., Marcucci, Guido, Pullarkat, Vinod, Aldoss, Ibrahim

Get full text

An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia by Othman, Tamer A, Tenold, Matthew E, Moskoff, Benjamin N, Azenkot, Tali, Jonas, Brian A

“…Older patients with acute myeloid leukemia (AML) ineligible for conventional chemotherapy have historically received low-intensity treatments, if any, and have…”
Get more information